Detailed dose evidence documented for CJC-1295 in its monograph — reference only, not dosing recommendations.
Reference only — not a dosing recommendation.
Not established
No approved labeled regimen
No established or recommended human dose.
Not applicable. No FDA-approved, EMA-authorized, or Health Canada-authorized CJC-1295 product was identified in the registers reviewed.
Studied in trials
Studied regimens (not recommendations)
Studied in trials — not a recommended dose
No established or recommended human dose. Published human pharmacology studies examined single SC exposures of 30–250 mcg/kg and limited repeat exposures of 20–60 mcg/kg given two or three times at weekly or 2-week intervals. These were experimental exposures in healthy volunteers, not dose-finding for a therapeutic indication.
Not established
What is not established
No effective therapeutic dose has been determined
No therapeutic regimen, duration, or maintenance schedule has been established
No published long-term human exposure data
No dose for the non-DAC ("without DAC") variant has been studied in humans